Population health programs seek to improve the health outcomes broadly of populations as opposed to focusing on individuals. A population health paradigm can provide faster and better access to innovation- and better guidance for consumers. The Food and Drug Administration should use a population health context to meet 21st century expectations for pharmaceutical risk.
This article was published in Health Affairs.
Read or print the article